Tags: Drug.

Tecovirimat (ST-246) is an antiviral with activity against orthopoxviruses such as smallpox and is currently undergoing clinical trials. It was previously owned by Viropharma and discovered in collaboration with scientists at USAMRIID. It is currently owned and is synthesized by SIGA Technologies a drug development company in the biodefense arena. It works by blocking cellular transmission of the virus thus preventing the disease.

Tecovirimat.svg
FDA UNII code
F925RR824R
IUPAC name
N-35-dioxo-4- azatetracyclo[5.3.2.0^26.0^810]dodec-11-en-4- yl-4-(trifluoromethyl)benzamide

Loading...

This page contains content from the copyrighted Wikipedia article "Tecovirimat"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.